MUMBAI, India
As India launches an ambitious effort to vaccinate 300 million people against the coronavirus within six months, it is employing two vaccines both manufactured domestically but approved under very different circumstances.
One is CoviShield, the vaccine developed by Britain’s AstraZeneca and Oxford University, which clinical trials show is about 70% effective in preventing COVID-19 and is being manufactured in India by the Serum Institute, the country’s largest drugmaker.
The other is Covaxin, developed by an Indian company in conjunction with the government but whose performance in late-stage clinical trials has yet to be published. Health authorities nevertheless approved the vaccine for “restricted emergency use.”
At what cost is govt sourcing Serum s Covishield, Bharat Biotech s Covaxin – Explained
Premium
A health worker shows a box containing COVID-19 vaccine inside cold storage at Civil Hospital in Ahmedabad,
(AP)
The government is sourcing a total of 55 lakh doses from Hyderabad-based Bharat Biotech s Covaxin vaccine
The health ministry today said that 110 lakh (or 1.1 crore) doses of COVISHIELD vaccine are being procured from SII at the cost of Rs. 200/ dose (excluding taxes)
Share Via
Read Full Story
As the country gears up for mega Covid-19 vaccination drive slated to start from 16 January, the Union Health Ministry on Tuesday gave a detailed clarification on the Indian prices of the two Covid-19 vaccines approved for emergency use authorization.
Vaccine drive accelerates, doses reach far corners of India
SECTIONS
Last Updated: Jan 13, 2021, 05:56 PM IST
Share
Synopsis
From Assam to Goa and from Jammu and Kashmir to Kerala, the vaccines were carefully and swiftly transported to far corners of the country, a day after the first consignment of the Covishield vaccine from the Oxford/AstraZeneca stable rolled out of the Serum Institute of India manufacturing facility in Pune.
AP
New Delhi: India s drive against COVID-19 gathered momentum on Wednesday with planes carrying vaccines flying into airports across the country from where the precious cargo was dispatched to small cities and towns in readiness for the inoculation exercise beginning January 16.
Synopsis
The government has already placed an order for 11 million doses from Serum Institute. In addition, 550,000 doses have been ordered from Bharat Biotech. The order to Pune-based Serum Institute is priced at ₹220 for one dose of the injection and that to Hyderabad-based Bharat Biotech is at ₹309, inclusive of taxes.
Agencies
While the bulk of the early shots will be Serum Institute’s as it has greater capacities and more stocks, Bharat Biotech will ramp up its production levels.
New Delhi: The government has approved the purchase of close to 70 million Covid-19 vaccines in the first phase of the inoculation programme. The bulk around 60 million jabs will be ordered from Serum Institute of India, while up to 10 million shots will be sourced from Bharat Biotech.
Karnataka receives 6 5-lac doses of Covishield vaccine from Pune daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.